Castle Biosciences, headquartered in Friendswood, Texas, is a dermatological cancer company that provides genomic tests for skin cancers and mental health conditions. The firm went public in July 2019 and employs 610 people.
Frank Stokes sold 7,000 shares of CSTL on 3 March at $27.81 per share, worth a total of $195K. They now own 54,183 CSTL shares, or a 12% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.